ClinicalTrials.gg
Drug

Thyroxine clinical trials

Also written Synthroid, Levothyroxin and Euthyrox.

studies test it
112
open now
20
in phase 3
19
first study started
2002

How each study uses Thyroxine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Thyroxine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Aug 2000 · UNITHROID · NDA 021210 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Levothyroxine
49
Levothyroxine Sodium
9
Thyroxine
9
L-thyroxine
7
Levothyroxine Sodium (LT4) Tablets
3

Brand

Synthroid
12
Euthyrox
5
Tirosint®-SOL
2
Eltroxin
2
Tirosint
1
Levoxyl
1
Unithroid
1

Development codes

XP-8121
1

Other names

Levothyroxin
8
T4
1

Studies by the year they started

112 studies that test it; most in 2015 (9)

Studies that test Thyroxine, by start year
YearStudies
20021
20036
20044
20054
20064
20073
20081
20092
20102
20115
20124
20136
20148
20159
20165
20174
20182
20194
20205
20218
20226
20233
20246
20257
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
16
Phase 2
12
Phase 3
19
Phase 4
36
No phase
33

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 98

Insel Gruppe AG, University Hospital Bern (6) · Mylan Pharmaceuticals Inc (4) · Ain Shams University (3) · Shandong Provincial Hospital (3) · VA Office of Research and Development (2) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2) · IBSA Institut Biochimique SA (2) · University of Pennsylvania (2)

Often tested with

Tested in the same studies.

Triiodothyronine (8) · Thyroid (USP) (2) · MK-0616 (1) · Enlicitide (1) · Methylprednisolone (1) · Glyburide (1) · Colesevelam (1) · Sorafenib (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7, 3 in phase 3

Studies that test Thyroxine, phase 3 first.

Studies

Open first, then newest update. How each study uses Thyroxine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 112

See all 112 studies that test Thyroxine →

Given beside what is tested · 13 — Thyroxine is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with Thyroxine

Codes

What other systems call Thyroxine · ClinicalTrials.gg INT008325

  • MeSH (NLM) D013974ThyroxineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) Q51BO43MG4LEVOTHYROXINEConfirmed FDA, NLM, Wikidata
  • RxNorm 10582Confirmed FDA, Wikidata
  • Wikidata Q106345689L-thyroxine zwitterionConfirmed FDA, NLM, Wikidata
  • Wikidata Q773449L-thyroxineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62080LevothyroxineOne source FDA
  • DrugBank DB00451One source Wikidata

Also registered as levothyroxine sodium (UNII 9J765S329G · RxNorm 40144).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.